28 April 2025
Pharmaceuticals | Top 5 Selected Papers Published in 2024 in the Section “Pharmaceutical Technology”

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We invite you to explore the following top five papers published in 2024 in the “Pharmaceutical Technology” Section:
1. “Nanoparticle-Mediated Drug Delivery Systems for Precision Targeting in Oncology”
by Kamelia Hristova-Panusheva, Charilaos Xenodochidis, Milena Georgieva and Natalia Krasteva
Pharmaceuticals 2024, 17(6), 677; https://doi.org/10.3390/ph17060677
Available online: https://www.mdpi.com/1424-8247/17/6/677
2. “Current Strategies and Therapeutic Applications of Mesenchymal Stem Cell-Based Drug Delivery”
by Yasunari Matsuzaka and Ryu Yashiro
Pharmaceuticals 2024, 17(6), 707; https://doi.org/10.3390/ph17060707
Available online: https://www.mdpi.com/1424-8247/17/6/707
3. “Magnetic Hyperthermia Therapy for High-Grade Glioma: A State-of-the-Art Review”
by Benjamin Rodriguez, Daniel Rivera, Jack Y. Zhang, Cole Brown, Tirone Young, Tyree Williams, Sakibul Huq, Milena Mattioli, Alexandros Bouras and Constantinos G. Hadjpanayis
Pharmaceuticals 2024, 17(3), 300; https://doi.org/10.3390/ph17030300
Available online: https://www.mdpi.com/1424-8247/17/3/300
4. “A Novel Combined Dry Powder Inhaler Comprising Nanosized Ketoprofen-Embedded Mannitol-Coated Microparticles for Pulmonary Inflammations: Development, In Vitro–In Silico Characterization, and Cell Line Evaluation”
by Heba Banat, Ildikó Csóka, Dóra Paróczai, Katalin Burian, Árpád Farkas and Rita Ambrus
Pharmaceuticals 2024, 17(1), 75; https://doi.org/10.3390/ph17010075
Available online: https://www.mdpi.com/1424-8247/17/1/75
5. “Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates”
by Fatemeh Zabihi, Mariam Cherri, Xiao Guo, Fiorenza Rancan, Fabian Schumacher, Ehsan Mohammadifar, Burkhard Kleuser, Wolfgang Bäumer, Michael Schirner, Annika Vogt et al.
Pharmaceuticals 2024, 17(1), 77; https://doi.org/10.3390/ph17010077
Available online: https://www.mdpi.com/1424-8247/17/1/77